Stock AMIX AUTONOMIX MEDICAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Autonomix Medical, Inc.

Equities

AMIX

US05330T1060

Delayed Nasdaq
Other stock markets
 14:40:00 2024-06-07 EDT 		5-day change 1st Jan Change
1.36 USD -24.44% Intraday chart for Autonomix Medical, Inc. -40.35% 0.00%
06-03 Autonomix Medical, Inc. Announces Approval of Protocol Amendment by Ethics Committee Upon Completion of All Lead-In Patients in Ongoing Human Clinical Trial CI
05-31 Autonomix Medical, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Autonomix Announces Approval of Protocol Amendment by Ethics Committee Upon Completion of All Lead-In Patients in Ongoing Human Clinical Trial
AQ
Autonomix Medical, Inc. Reports Full Year 2024 Financial Results and Provides Corporate Update
AQ
Autonomix Preclinical Study Successfully Demonstrates That Nerve Ablation Can Slow Tumor Metastasis in Pancreatic Cancer
AQ
Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series
AQ
Autonomix Enters into Agreement with NoiseFigure Research, Inc. to Develop Next Generation of its Proprietary Microchip
AQ
Autonomix to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar
AQ
Autonomix Medical Inc Covered in Benzinga Article Highlighting Innovative Nerve Treatment Tech
AQ
Autonomix Announces Issuance of U.S. Patent Covering Proprietary Catheter-Based Technology for the Treatment of Cancer Related Pain
AQ
Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment Technology
AQ
Autonomix Announces Positive Findings from Preclinical Study Demonstrating Potential to Improve Renal Denervation
AQ
Autonomix to Participate in the Virtual Investor Lunch Break: The Team Behind the AMIX Ticker
AQ
Autonomix to Present at the MedInvest Biotech & Pharma Investor Conference
AQ
 Autonomix (NASDAQ: AMIX) to Present at the Benzinga Virtual Healthcare Summit 2024
AQ
Autonomix Appoints Jennifer Cook as Chief Business Officer
AQ
Autonomix Completes First Three Patient Procedures in Human Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market
AQ
Autonomix Enrolls First Patients in Human Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market
AQ
Autonomix Signs Key Clinical Agreements in Preparation to Begin March 2024 Human Clinical Trial
AQ
Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Lunch Break: The Autonomix Opportunity
AQ
Autonomix Secures Principal Investigators and Completes Clinical Training for First Human Study
AQ
Autonomix Begins Human POC Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AMIX Stock
  4. News Autonomix Medical, Inc.
  5. Press Releases